Blogs

Categories

Select a Sub-Category

Films and Coatings
Pharmaceutical Packaging Components
Prefillable Systems
Self Injection Devices
Vial Containment Solutions
Washing and Sterilization
Reconstitution and Transfer Devices

Select a Sub-Category

Analytical Lab Services
Contract Manufacturing
Fill-Finish
Regulatory Support

Select a Sub-Category

Cell and Gene Therapy Packaging
Drug Development Process
Regulatory Challenges
Transitioning to Combination Products

Select a Sub-Category

Corporate Development
ESG/Sustainability
One West Team (Employee Culture)
Our Culture of Giving (Philanthropy)
Research and Development

Previous Blogs

Analytical Labs

By Lynn Yao

四月 03, 2020

随着医药科技不断发展和进步,中国的药品审评标准在不断改变和提高,过去的药品审评标准没有强制要求仿制药与原研药质量和疗效一致,所以有些药品在质量、疗效上与原研药存在一定差距,需要改进提高。自2015年开始,国家药品监督管理局(原国家食品药品监督管理总局)推出仿制药质量和疗效一致性评价,借以提高我国仿制药的质量和疗效。质量和疗效视为等同于原研产品的仿制药将在公立医院的招标和处方中享受优先待遇。